Filing Details

Accession Number:
0001638599-15-000381
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-03 16:20:35
Reporting Period:
2015-12-01
Filing Date:
2015-12-03
Accepted Time:
2015-12-03 16:20:35
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
810509 Navidea Biopharmaceuticals Inc. NAVB In Vitro & In Vivo Diagnostic Substances (2835) 311080091
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1195766 L Brent Larson 5600 Blazer Parkway, Suite 200
Dublin OH 43017-7550
Evp, Cfo, Treas & Sec'y No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-12-01 12,500 $1.50 222,237 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sales effected pursuant to a 10b5-1 trading plan adopted by Mr. Larson on March 13, 2015.
  2. Weighted average of sales prices ranging from $1.49 to $1.51 per share. Mr. Larson undertakes to provide upon request by the staff of the Securities and Exchange Commission, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price.